BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17356564)

  • 1. Human breast biomonitoring and environmental chemicals: use of breast tissues and fluids in breast cancer etiologic research.
    LaKind JS; Wilkins AA; Bates MN
    J Expo Sci Environ Epidemiol; 2007 Sep; 17(6):525-40. PubMed ID: 17356564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workshop report: identification of research needs breast cancer etiology.
    Friedenreich C; Marrett LD;
    Chronic Dis Can; 2001; 22(2):41-9. PubMed ID: 11525719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology for collecting, storing, and analyzing human milk for volatile organic compounds.
    Blount BC; McElprang DO; Chambers DM; Waterhouse MG; Squibb KS; Lakind JS
    J Environ Monit; 2010 Jun; 12(6):1265-73. PubMed ID: 20358052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?
    Brody JG; Rudel RA; Michels KB; Moysich KB; Bernstein L; Attfield KR; Gray S
    Cancer; 2007 Jun; 109(12 Suppl):2627-34. PubMed ID: 17503444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients.
    Mannello F; Tonti GA; Medda V; Simone P; Darbre PD
    J Appl Toxicol; 2011 Apr; 31(3):262-9. PubMed ID: 21337589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR; Sauter ER; Quinn TP; Deutscher SL
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection and use of exposure data from human milk biomonitoring in the United States.
    Fenton SE; Condon M; Ettinger AS; LaKind JS; Mason A; McDiarmid M; Qian Z; Selevan SG
    J Toxicol Environ Health A; 2005 Oct; 68(20):1691-712. PubMed ID: 16176916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research.
    LaKind JS; Amina Wilkins A; Berlin CM
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):184-208. PubMed ID: 15236953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a biomonitoring educational pamphlet for potential participants in a breast milk biomonitoring study.
    Dunn RL; Carey GB
    J Hum Lact; 2010 May; 26(2):183-6. PubMed ID: 20110562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
    Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
    Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid.
    Petrakis NL; Gruenke LD; Craig JC
    Cancer Res; 1981 Jun; 41(6):2563-5. PubMed ID: 7237447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive matrices in human biomonitoring: a review.
    Esteban M; CastaƱo A
    Environ Int; 2009 Feb; 35(2):438-49. PubMed ID: 18951632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental contaminants in breast milk.
    Nickerson K
    J Midwifery Womens Health; 2006; 51(1):26-34. PubMed ID: 16399607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.